Sarcoma Clinical Trials

A listing of Sarcoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

UPDATED

San Francisco California 94115

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

Santa Monica California 90404

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Colorado

UPDATED

Aurora Colorado 80045

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Florida

UPDATED

Jacksonville Florida 32224

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

Miami Florida 33136

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Georgia

UPDATED

Atlanta Georgia 30342

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Maryland

UPDATED

Baltimore Maryland 21287

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Massachusetts

UPDATED

Boston Massachusetts 02215

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Missouri

UPDATED

St. Louis Missouri 63110

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Nebraska

UPDATED

Omaha Nebraska 68114

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

New York

UPDATED

Lake Success New York 11042

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

New York New York 10032

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

New York New York 10065

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Ohio

UPDATED

Columbus Ohio 43210

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Pennsylvania

UPDATED

Philadelphia Pennsylvania 19111-2497

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Tennessee

UPDATED

Nashville Tennessee 37232-6307

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Texas

UPDATED

Dallas Texas 75235

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

Houston Texas 77030

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Wisconsin

UPDATED

Milwaukee Wisconsin 53226

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Australia

UPDATED

Adelaide 5000

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

Melbourne 3000

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

China

UPDATED

Guangzhou Guangdong 510000

A clinical research study of MASCT-I and Ifosfamide for the treatment of Advanced Cancer, Bladder Cancer or Soft Tissue Sarcoma

Germany

UPDATED

Aachen

A Phase 1/Phase 2 clinical study for patients with Refractory or Recurrent Solid Tumors, Rhabdomyosarcoma or Non-Rhabdomyosarcoma Soft Tissue Sarcoma

UPDATED

Bad Saarow 15526

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

Berlin 13125

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

Berlin 13125

Patients are needed to participate in a clinical research study of Olaratumab, Doxorubicin, Ifosfamide and Mesna to evaluate Soft Tissue Sarcoma

UPDATED

Essen 45122

Patients are needed to participate in a clinical research study of Olaratumab, Doxorubicin, Ifosfamide and Mesna to evaluate Soft Tissue Sarcoma

View More ▼

UPDATED

Freiburg

A Phase 1/Phase 2 clinical study for patients with Refractory or Recurrent Solid Tumors, Rhabdomyosarcoma or Non-Rhabdomyosarcoma Soft Tissue Sarcoma

UPDATED

Goettingen

A Phase 1/Phase 2 clinical study for patients with Refractory or Recurrent Solid Tumors, Rhabdomyosarcoma or Non-Rhabdomyosarcoma Soft Tissue Sarcoma

UPDATED

Hanover 30625

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

Munich 81377

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

Regensburg 93053

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

Ulm 89081

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Hungary

UPDATED

Szolnok 5000

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Israel

UPDATED

Haifa 31096

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

Petah Tiqva 4941492

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

Tel Hashomer 5265601

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

Tel-Aviv Jaffa 6423906

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Italy

UPDATED

Candiolo 10060

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

Milano 20133

Patients are needed to participate in a clinical research study of Olaratumab, Doxorubicin, Ifosfamide and Mesna to evaluate Soft Tissue Sarcoma

UPDATED

Torino 10153

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

Poland

UPDATED

Warszawa 02-781

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

United Kingdom

UPDATED

Edinburgh EH4 2XU

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

London NW1 2BU

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

London SW3 6JJ

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced

UPDATED

Merseyside CH63 4JY

A clinical research study of Olaratumab (LY3012207), Gemcitabine, Docetaxel and Placebo for the treatment of Soft Tissue Sarcoma, Advanced